EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    1.14.11.1 | Ascorbic Acid Deficiency |
1962562 |
Ascorbic acid and carnitine biosynthesis. |
unassigned |
0 |
| 1.14.11.1 | Carcinogenesis |
32690540 |
Identification of BBOX1 as a Therapeutic Target in Triple-Negative Breast Cancer. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
3
4
0 |
| 1.14.11.1 | Colorectal Neoplasms |
31984680 |
BBOX1-AS1 contributes to colorectal cancer progression by sponging hsa-miR-361-3p and targeting SH2B1. |
ongoing research
unassigned |
4
0 |
| 1.14.11.1 | Diabetic Nephropathies |
30819181 |
Bioinformatics-based discovery of the urinary BBOX1 mRNA as a potential biomarker of diabetic kidney disease. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
2
3
1
0 |
| 1.14.11.1 | Heart Failure |
10812052 |
Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
1
4
0 |
| 1.14.11.1 | Heart Failure |
10942199 |
MET-88, a gamma-butyrobetaine hydroxylase inhibitor, improves cardiac SR Ca2+ uptake activity in rats with congestive heart failure following myocardial infarction. |
therapeutic application
unassigned |
2
0 |
| 1.14.11.1 | Hyperthyroidism |
11964131 |
Thyroid hormone controls carnitine status through modifications of gamma-butyrobetaine hydroxylase activity and gene expression. |
ongoing research
unassigned |
4
0 |
| 1.14.11.1 | Hypothyroidism |
11964131 |
Thyroid hormone controls carnitine status through modifications of gamma-butyrobetaine hydroxylase activity and gene expression. |
ongoing research
unassigned |
4
0 |
| 1.14.11.1 | Kidney Diseases |
30819181 |
Bioinformatics-based discovery of the urinary BBOX1 mRNA as a potential biomarker of diabetic kidney disease. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
2
3
1
0 |
| 1.14.11.1 | Myocardial Infarction |
10812052 |
Beneficial effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor in rats with heart failure following myocardial infarction. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
1
4
0 |
